Background: Recent studies have shown that heat shock proteins (HSPs) play a role in pathogenesis of Alzheimer's disease.
Introduction
Dementia is a disorder that is characterized by impairment of memory and at least one other cognitive function such as aphasia, apraxia, agnosia and loss of executive function. These caused loss of previous level of function [1] . Alzheimer disease (AD) is the most common form of dementia in the elderly, and causes 60 to 80 percent of dementia in elderly [2] [3] [4] .
Heat shock proteins (HSP) are a group of proteins that impressed by heat shock, the subgroup of these proteins are related proteins functionally take part in the folding and unfolding of other proteins. Their expression is increased in high temperatures or other stress that cells are exposed [5] . The upregulation of the heat shock proteins is important to the heat shock response and is induced by heat shock factor (HSF) [6] . Heat shock proteins are named by their molecular weight. For example, HSP60 has 60 kilodaltons (kd) molecular weight [7] .
Recent studies have shown that these proteins have an important role in the pathogenesis of Alzheimer's disease. For example, HSP 70 family has been involved in the pathology of Alzheimer's disease and its major clinical and pathological characteristics like neurofibrillary tangles and β-amyloid [8] [9] [10] . Aβ plaques are important in pathogenesis of Alzheimer's disease and they are mis-folded proteins, Syndromes because Alzheimer's disease is an example of disorder in proteinfolding [8] [9] [10] . HSPs are the important chaperones for reconciliation of proper folding of proteins [11] .
On the other hand, small heat shock proteins like HSP27 ubiquitin, α-crystallin, HSP20 and others have chaperone activity, thermotolerance, inhibition of apoptosis, regulation of cell development, and cell differentiation. They also have signal transduction effect [12] . HSP27 provide thermotolerance, cytoprotection, and in time of stressful conditions support the cell survival. HSP27 also works as a chaperone independent with ATP and partially stabilized denatured proteins and also inhibit aggregation of proteins which ensures refolding by the HSP70-complex and involved in the apoptotic signaling pathway. HSP27 interacts with the outer mitochondrial membrane and inhibits the activation of procaspase-9 [13] . The phosphorylated form of HSP27 inhibits Daxx apoptotic protein and with Fas and Ask1, it prevents the association of Daxx [14] .
There is increasing evidence for the involvement of the heat shock proteins family in neurodegenerative disorders. It has been shown that Aβ plaques and HSP70 are localized together [15] . Recent evidence suggests that HSP70 suppresses formation of NFTs with enhanced tau solubility and tau binding to microtubules [16] . Control of the response of cells to stress involving induction of HSPs in differentiated neurons gives a potential therapeutic method to make changes in neuronal proteins that start pathogenic cascades resulting in human neurodegenerative disorders. Given that the etiology of Alzheimer's disease is still unknown, the understanding of HSPs role in Alzheimer's disease and other cognitive disorders can help much more to understanding the etiology and treatment of Alzheimer's disease. In this review article, we investigated the role of proteins in pathogenesis of cognitive disorders such as Alzheimer's disease. ▪ Loss of word comprehension ability, for example, inability to respond to "Your daughter is on the phone" (aphasia)
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▪
Loss of ability to perform complex tasks involving muscle coordination, for example, bathing or dressing (apraxia)
Loss of ability to recognize and use familiar objects, for example, clothing (agnosia)
Loss of ability to plan, organize, and execute normal activities, for example, going shopping
The problems in "A" represent a substantial decline from previous abilities and cause significant problems in everyday functioning.
C. The problems in "A" begin slowly and gradually become more severe. F. The problems in "A" are not caused by another mental illness: Depression, schizophrenia, etc.
Criteria for diagnosis of probable Alzheimer's disease (From DSM-IV-TR)
Dementia established by clinical examination, documented by a standard test of cognitive function (e.g. Mini-Mental State Examination, Blessed Dementia Scale, etc.), and confirmed by neuropsychological tests Significant deficiencies in two or more areas of cognition, for example, word comprehension and task-completion ability
Progressive deterioration of memory and other cognitive functions
No loss of consciousness
Onset from age 40 to 90, typically after 65
No other diseases or disorders that could account for the loss of memory and cognition
A diagnosis of probable Alzheimer's disease is supported by:
Progressive deterioration of specific cognitive functions: Language (aphasia), motor skills (apraxia), and perception (agnosia)
Impaired activities of daily living and altered patterns of behavior
A family history of similar problems, particularly if confirmed by neurological testing
The following laboratory results:
Normal cerebrospinal fluid (lumbar puncture test)
Normal electroencephalogram (EEG) test of brain activity
Evidence of cerebral atrophy in a series of computed tomography (CT) scans
Other features consistent with Alzheimer's disease:
Plateaus in the course of illness progression CT findings normal for the person's age Associated symptoms, including depression, insomnia, incontinence, delusions, hallucinations, weight loss, sex problems, and significant verbal, emotional, and physical outbursts
Other neurological abnormalities, especially in advanced disease, including increased muscle tone and a shuffling gait
Features that decrease the likelihood of Alzheimer's disease:
Sudden onset Such early symptoms as seizures, gait problems, and loss of vision and coordination
Methods
All published studies concerning HSP and Neurocognitive disorders and Alzheimer disease were included from 1970 until 2014 January. Publications were identified from the following electronic databases: Medline/PubMed, Scopus, Google Scholar, Embase, ISI Web of Knowledge, Biological Abstracts and Chemical Abstracts.
Study eligibility criteria
To include all of studies in electronic databases, keywords such as Heat Shock Protein (HSP); Neurocognitive disorders; Alzheimer disease; Dementia were used. After search of database with above keywords we found 337 papers published. Then we narrowed our findings to 40 articles and reviewed them. Subsequently, the ISSN: 2380-6036 • HSP27 managed to halt the death of polyglutamine [poly (Q)] without any confrontation with the attack by poly (Q).
• HSP27 is able to take some measures to reduce probability of death caused via cell mediation by poly (Q), for example it can lock cytochrome c and ban mitochondrial death pathway, or employ some protection forms in face of reactive oxygen species (ROS).
•
Since ROS was decreased y HSP27 in cells expressing mutant Huntongton, it can be concluded that HSP27 actually proves useful in protecting cells faced with oxidative stress.
• Poly(Q) mutation can generate ROS which is capable of direct interference leading to death of a cell. This is while HSP27 is against such process.
[18]
Wilhelmus MM et al.
HSP20 HSPB2/B3
• Inside the brains of people suffering from Alzheimer, we can witness a co-habitation of HSP20 and HSPB2/B3 with Abeta deposition in senile plaques as well as cerebral amyloid angiopathy.
• Except for HSPB2/B3, HSP20, HSP27 and alphaB-crystallin border with Abeta (both D-Abetal-40 and Abetal-42) and work for reduction or complete prevention of an attack towards mature fibrils by D-Abeta1-40.
•
HSPs may regulate Abeta aggregation and act as an adversary to prevent Abeta from performing its biological duties, though the amount of interplay between them is based on the type of HSPs and Abeta peptide. Lowenstein DH et al.
HSP72
• mRNA for calbindin-D28K, grp78, and HSP72 increased in the hippocampus following seizures.
•
The increases in HSP72 and grps indicate the occurence of a generalized stress response.
[21]
Luo W et al.
HSP90
• Inhibition of HSP90 in cellular and mouse models of tauopathies leads to a reduction of the pathogenic activity of cyclin-dependent protein kinase 5, WT Tau protein and results in elimination of aggregated Tau.
• HSP90 played important roles by in maintaining and facilitating the degenerative phenotype in Neurodegenerative diseases.
[22]
Li CY et al.
HSP70
• HSP70 has been shown to act as an inhibitor of apoptosis. • HSP20, HSP27 and HSPB2 were expressed in classic senile plaques, and HSP20 expression in diffuse senile plaques.
• HSPB2 was expressed in cerebral amyloid angiopathy. • HSP20, HSP27 and HSPB2 may be involved in the pathogenesis of either senile plaques or cerebral amyloid angiopathy in AD.
[24]
Perez N et al.
HSP 72, HSP 73
• Postmortem cortical tissues from Alzheimer's disease cases were found to contain significantly higher levels of the heat shock proteins HSP 72 and HSP 73 than control cortical tissues.
• Induction of HSP 72 and HSP 73 is associated with Alzheimer's disease and that cotranslational processes are affected by this induction.
[25]
Magrané J et al.
HSP 70
• One of the widely recognized early symptoms of Alzheimer disease (AD) is the accumulation of intracellular beta-amyloid 42 or (Abeta42).
• Expression of Abeta42 encouraged rapid generation of HSP70 proteins in neurons and protected HSP70 overexpression neurons which were rescued from poisonous effects of accumulation of intercellular Abeta.
[15]
Hamos JE et al.
HSP72, GRP78
• Major changes occurred for HSP72 and GRP78 during expression in AD.
•
In AD patients, particularly in nutritic plaques and neurofibrillary tangles of them. A drastic increase of HSP72 was observed.
• An increase of GRP78 was observed in AD, albeit solely in normal neurons which cytologically stayed intact. In particular in the CA3 subfield of the hippocampus and deeply-located layers of entorhinal cortex.
[26]
Castegna A, et al.
DRP-2, HSC-71
• Protein 2 (DRP-2), which is associated with dihydropyrimidinase, indicates a form of contribution for incapacitated mechanism of the formation of neural network in AD.
• It was found out that the cytosolic enzyme alpha-enlase is a target of proteinoxidation which, in case of occurrence of pathological Ads, is involved in glycolitic pathway.
• Increased level of oxidation in AD brain was revealed by the heat shock cognate 71 (HSC-71).
[ 27] therapeutic approaches to Alzheimer disease and the role of HSPs were analyzed.
The criteria for Alzheimer disease are shown in Table 1 .
Results
We investigated the previous studies on role of HSPs in Alzheimer disease and other causes of dementia. The results are shown in Table  2 .
Discussion
Alzheimer's disease is a progressive neurodegenerative disorder characterized by loss of memory and cognition and by pathological lesions such as senile plaques, cerebral amyloid angiopathy and neurofibrillary tangles, predominantly consisting of the incorrectly folded proteins amyloid-beta and tau respectively [24] . Amyloid-beta peptide is a main element of senile plaques and has an important role to pathogenesis of the disease [28] . The heat shock proteins constitute molecular chaperones able to act with proteins that are folded incorrectly. It has been shown that impaired protein folding and related decrease in protein function is important factor in the process of neurodegeneration [27] . HSPs play some other roles in the body. For example HSP70 acts as a damage-associated molecular pattern; activates and regulates signaling cascades [29, 30] and acts on neurons and numerous cell types. We reviewed the literature role of proteins in the pathogenesis of cognitive disorders such as Alzheimer's disease.
This review showed that expression of HSP can be related to the severity and duration of symptoms of Alzheimer's disease. Study of Renkawek et al. showed the highest expression of wherever rich in terms of senile plaques, Hirano bodies, neurofibrillary tangles as well as in some hippocampal neurons, degenerative astrocytes demonstrated the highest expression of HSP27 [31] . Also, severity of AD and period of lasting dementia led to an increase of HSP27 expression. Thus we can conclude that higher expression of HSP27 is related to AD pathology, especially in astrocytes.
It is proved that HSPs make some contributions to neuronal survival and communication which exists between glial cells and neurons. In a study by May et al. it was found that glial cells are capable of providing HSP70 to neurons and that when faced with stress, neurons have a limited ability to generate HSP70 [32] . The ability of HSPs to defend nervous system against various stress and neurodegenerative diseases was known previously [33] [34] [35] . Another study by Guzhova et al. showed that it is possible to transfer HSP70 from adjacent glial cells to axons, it was also revealed that extracellular HSP70 is able to defend motor neurons [36] . Additionally, a study by Prahlad V et al. indicated that heat-sensing neurons would prevent heat shock response to be implanted with chronic stress. Moreover, HSP70 not only saves vital components of the cell, but also saves the cell in general [37] . It hampers apoptosis and raises the chances of cells' survival along with improving cell's proteins integration [38, 39] .
The study of Hoshino et al. showed that HSPs caused expression of a growth factor that activates phagocytosis by microglia named A-degrading enzyme that is a marker of microglial activation and it increased overexpression of reduced plaque formation and neuronal and synaptic loss in Alzheimer's disease [40, 41] .
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Limitations
We reviewed only some electronic database and other literatures were not reviewed.
Conclusion
This review showed that heat shock proteins (HSPs) help refold or degrade mis-folded proteins, reduce abnormal protein accumulation and synaptic dysfunction, neuronal degeneration and cognitive decline in Alzheimer's disease and improves the associated symptoms.
